Načítá se...
Structural insights into selective agonist actions of tamoxifen on human Estrogen Receptor alpha
Tamoxifen, an anti-estrogenic ligand in breast tissues and being used as a first-line treatment in ER-positive breast cancers, is found to develop resistance followed by resumption of growth of the tumor in about 30% of cases. Whether tamoxifen starts assisting in proliferation in such cases or ther...
Uloženo v:
| Vydáno v: | J Mol Model |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4379705/ https://ncbi.nlm.nih.gov/pubmed/25060147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00894-014-2338-x |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|